SGLT2 inhibitors as potential anticancer agents
Food and Drug Administration (FDA)-approved GLP-1 receptor agonists, with a particular focus on efficacy and clinical studies
Jortzik E, Becker K (2012) Thioredoxin and glutathione systems in Plasmodium falciparum
Others work on cellular repair routes, reducing oxidative stress and aiding steroidogenic cells to restore enzyme functionality
Propionyl-L-carnitine (500 mg/kg, i.p., 10 successive days) prevents the progression of Cisplatin (HY-17394)-induced cardiomyopathy in a carnitine-depleted rat model [9]
Kimberly Dennis, co-founder, CEO, and chief medical officer at SunCloud Health and Stephanie Ryan, clinical director at Eating Disorder Treatment Centers (EDTC) shared with BHB